Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

265 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Expert clinical management of autoimmune hepatitis in the real world.
Liberal R, de Boer YS, Andrade RJ, Bouma G, Dalekos GN, Floreani A, Gleeson D, Hirschfield GM, Invernizzi P, Lenzi M, Lohse AW, Macedo G, Milkiewicz P, Terziroli B, van Hoek B, Vierling JM, Heneghan MA; International Autoimmune Hepatitis Group (IAIHG). Liberal R, et al. Among authors: heneghan ma. Aliment Pharmacol Ther. 2017 Mar;45(5):723-732. doi: 10.1111/apt.13907. Epub 2016 Dec 22. Aliment Pharmacol Ther. 2017. PMID: 28004405 Free article.
Review article: the modern management of autoimmune hepatitis.
Yeoman AD, Longhi MS, Heneghan MA. Yeoman AD, et al. Among authors: heneghan ma. Aliment Pharmacol Ther. 2010 Apr;31(8):771-87. doi: 10.1111/j.1365-2036.2010.04241.x. Epub 2010 Jan 19. Aliment Pharmacol Ther. 2010. PMID: 20096018 Free article. Review.
Letter: guidelines for the management of autoimmune hepatitis.
Gleeson D, Heneghan MA. Gleeson D, et al. Among authors: heneghan ma. Aliment Pharmacol Ther. 2014 Jan;39(1):114-5. doi: 10.1111/apt.12549. Aliment Pharmacol Ther. 2014. PMID: 24299327 Free article. No abstract available.
In autoimmune hepatitis type 1 or the autoimmune hepatitis-sclerosing cholangitis variant defective regulatory T-cell responsiveness to IL-2 results in low IL-10 production and impaired suppression.
Liberal R, Grant CR, Holder BS, Cardone J, Martinez-Llordella M, Ma Y, Heneghan MA, Mieli-Vergani G, Vergani D, Longhi MS. Liberal R, et al. Among authors: heneghan ma, ma y. Hepatology. 2015 Sep;62(3):863-75. doi: 10.1002/hep.27884. Epub 2015 Jun 18. Hepatology. 2015. PMID: 25953611 Free article.
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways.
Cordell HJ, Han Y, Mells GF, Li Y, Hirschfield GM, Greene CS, Xie G, Juran BD, Zhu D, Qian DC, Floyd JA, Morley KI, Prati D, Lleo A, Cusi D; Canadian-US PBC Consortium; Italian PBC Genetics Study Group; UK-PBC Consortium; Gershwin ME, Anderson CA, Lazaridis KN, Invernizzi P, Seldin MF, Sandford RN, Amos CI, Siminovitch KA. Cordell HJ, et al. Nat Commun. 2015 Sep 22;6:8019. doi: 10.1038/ncomms9019. Nat Commun. 2015. PMID: 26394269 Free PMC article.
Reply to "Further considerations in autoimmune hepatitis".
Lohse AW, Chazouilleres O, Dalekos G, Drenth JP, Heneghan M, Hofer H, Lammert F, Lenzi M; EASL Clinical Practice Guidelines: Autoimmune hepatitis panel. Electronic address: easloffice@easloffice.eu. Lohse AW, et al. J Hepatol. 2016 Jun;64(6):1458-9. doi: 10.1016/j.jhep.2016.02.026. Epub 2016 Feb 22. J Hepatol. 2016. PMID: 26916526 No abstract available.
265 results